<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1258"/><api:result><api:object category="publication" id="1258" last-affected-when="2024-03-16T19:22:54.187+00:00" last-modified-when="2024-03-16T19:22:54.187+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1258" created-when="2010-05-17T13:47:34.563+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>2002-01-13</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="1420713" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1046/j.1464-5491.2000.00308.x" last-modified-when="2023-11-04T11:16:40.857+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;jats:title&gt;Summary&lt;/jats:title&gt;&lt;jats:p&gt; &lt;jats:bold&gt;Aims&lt;/jats:bold&gt; Screening for asymptomatic Type 2 diabetes mellitus has been advocated on the grounds that diabetes is a common condition associated with increased morbidity and mortality, but uncertainty remains about the impact of early treatment. This study aimed to determine whether the potential benefits of screening are likely to outweigh the potential harm and to explore which variables significantly influence the balance of benefit and harm resulting from screening.&lt;/jats:p&gt;&lt;jats:p&gt; &lt;jats:bold&gt;Methods&lt;/jats:bold&gt; A decision analysis comparing the relative impact of using a single fasting blood glucose screening test, between the ages of 45 and 60 years, with the impact of not screening. The model weighs the increase in quality adjusted life years (QALYs) from reduction in microvascular and cardiovascular complications against the potential decrease in QALYs associated with earlier diagnosis and treatment in an asymptomatic population.&lt;/jats:p&gt;&lt;jats:p&gt; &lt;jats:bold&gt;Results&lt;/jats:bold&gt; The baseline model suggests a saving of 10 QALYs for every 10 000 individuals screened: a gain of four from postponed microvascular complications and 17 from avoided cardiovascular complications, as opposed to a loss of 11 as a result of earlier diagnosis in screening detected cases. The balance of benefit and harm is sensitive to baseline cardiovascular risk, the effectiveness of cardiovascular interventions and the relative disutility assigned to early diagnosis and treatment for an individual without symptoms.&lt;/jats:p&gt;&lt;jats:p&gt; &lt;jats:bold&gt;Conclusions&lt;/jats:bold&gt; The immediate disutility of earlier diagnosis and additional treatment may be greater than the potential long‐term benefit from postponing microvascular complications. Screening decisions should therefore be based largely on consideration of cardiovascular risk and the availability of evidence based interventions to reduce cardiovascular risk.&lt;/jats:p&gt;</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1464-5491</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Diabetic Medicine</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>13</api:day><api:month>1</api:month><api:year>2002</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1046/j.1464-5491.2000.00308.x</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>10</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="358344" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033914017" last-modified-when="2020-09-01T23:42:31.54+01:00"><api:citation-count>19</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>Aims: Screening for asymptomatic Type 2 diabetes mellitus has been advocated on the grounds that diabetes is a common condition associated with increased morbidity and mortality, but uncertainty remains about the impact of early treatment. This study aimed to determine whether the potential benefits of screening are likely to outweigh the potential harm and to explore which variables significantly influence the balance of benefit and harm resulting from screening. Methods: A decision analysis comparing the relative impact of using a single fasting blood glucose screening test, between the ages of 45 and 60 years, with the impact of not screening. The model weighs the increase in quality adjusted life years (QALYs) from reduction in microvascular and cardiovascular complications against the potential decrease in QALYs associated with earlier diagnosis and treatment in an asymptomatic population. Results: The baseline model suggests a saving of 10 QALYs for every 10 000 individuals screened: a gain of four from postponed microvascular complications and 17 from avoided cardiovascular complications, as opposed to a loss of 11 as a result of earlier diagnosis in screening detected cases. The balance of benefit and harm is sensitive to baseline cardiovascular risk, the effectiveness of cardiovascular interventions and the relative disutility assigned to early diagnosis and treatment for an individual without symptoms. Conclusions: The immediate disutility of earlier diagnosis and additional treatment may be greater than the potential long-term benefit from postponing microvascular complications. Screening decisions should therefore be based largely on consideration of cardiovascular risk and the availability of evidence based interventions to reduce cardiovascular risk.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="AU"><api:line type="organisation">The University of Sydney</api:line><api:line type="city">Sydney</api:line><api:line type="country">Australia</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Faculty of Medicine, Dentistry and Health</api:line><api:line type="city">Sheffield</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">6603784604</api:identifier></api:identifiers></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="AU"><api:line type="organisation">The University of Sydney</api:line><api:line type="city">Sydney</api:line><api:line type="country">Australia</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006277368</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10975217</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Diabetic Medicine</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>2</api:day><api:month>8</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: A decision analytic approach</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="1258" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10975217" last-modified-when="2020-04-29T06:11:12.603+01:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>AIMS: Screening for asymptomatic Type 2 diabetes mellitus has been advocated on the grounds that diabetes is a common condition associated with increased morbidity and mortality, but uncertainty remains about the impact of early treatment. This study aimed to determine whether the potential benefits of screening are likely to outweigh the potential harm and to explore which variables significantly influence the balance of benefit and harm resulting from screening. METHODS: A decision analysis comparing the relative impact of using a single fasting blood glucose screening test, between the ages of 45 and 60 years, with the impact of not screening. The model weighs the increase in quality adjusted life years (QALYs) from reduction in microvascular and cardiovascular complications against the potential decrease in QALYs associated with earlier diagnosis and treatment in an asymptomatic population. RESULTS: The baseline model suggests a saving of 10 QALYs for every 10,000 individuals screened: a gain of four from postponed microvascular complications and 17 from avoided cardiovascular complications, as opposed to a loss of 11 as a result of earlier diagnosis in screening detected cases. The balance of benefit and harm is sensitive to baseline cardiovascular risk, the effectiveness of cardiovascular interventions and the relative disutility assigned to early diagnosis and treatment for an individual without symptoms. CONCLUSIONS: The immediate disutility of earlier diagnosis and additional treatment may be greater than the potential long-term benefit from postponing microvascular complications. Screening decisions should therefore be based largely on consideration of cardiovascular risk and the availability of evidence based interventions to reduce cardiovascular risk.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="AU"><api:line type="full">Department of Public Health &amp; Community Medicine, University of Sydney, Australia. e.goyder@sheffield.ac.uk</api:line></api:address></api:addresses><api:email-address>e.goyder@sheffield.ac.uk</api:email-address></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10975217</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Diabet Med</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Blood Glucose</api:keyword><api:keyword scheme="mesh">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh">Decision Trees</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh">Fasting</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Mass Screening</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>22</api:day><api:month>12</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="882335" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10975217" last-modified-when="2023-02-14T17:47:02.103+00:00"><api:citation-count>10</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>&lt;h4&gt;Aims&lt;/h4&gt;Screening for asymptomatic Type 2 diabetes mellitus has been advocated on the grounds that diabetes is a common condition associated with increased morbidity and mortality, but uncertainty remains about the impact of early treatment. This study aimed to determine whether the potential benefits of screening are likely to outweigh the potential harm and to explore which variables significantly influence the balance of benefit and harm resulting from screening.&lt;h4&gt;Methods&lt;/h4&gt;A decision analysis comparing the relative impact of using a single fasting blood glucose screening test, between the ages of 45 and 60 years, with the impact of not screening. The model weighs the increase in quality adjusted life years (QALYs) from reduction in microvascular and cardiovascular complications against the potential decrease in QALYs associated with earlier diagnosis and treatment in an asymptomatic population.&lt;h4&gt;Results&lt;/h4&gt;The baseline model suggests a saving of 10 QALYs for every 10,000 individuals screened: a gain of four from postponed microvascular complications and 17 from avoided cardiovascular complications, as opposed to a loss of 11 as a result of earlier diagnosis in screening detected cases. The balance of benefit and harm is sensitive to baseline cardiovascular risk, the effectiveness of cardiovascular interventions and the relative disutility assigned to early diagnosis and treatment for an individual without symptoms.&lt;h4&gt;Conclusions&lt;/h4&gt;The immediate disutility of earlier diagnosis and additional treatment may be greater than the potential long-term benefit from postponing microvascular complications. Screening decisions should therefore be based largely on consideration of cardiovascular risk and the availability of evidence based interventions to reduce cardiovascular risk.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="AU"><api:line type="full">Department of Public Health &amp; Community Medicine, University of Sydney, Australia. e.goyder@sheffield.ac.uk</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0003-3691-1888</api:identifier></api:identifiers></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1464-5491</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10975217</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>false</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Diabetic medicine : a journal of the British Diabetic Association</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Blood Glucose</api:keyword><api:keyword scheme="mesh">Mass Screening</api:keyword><api:keyword scheme="mesh">Fasting</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Decision Trees</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>7</api:day><api:month>9</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="2734865" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1039865957" last-modified-when="2024-03-16T19:22:54.193+00:00"><api:citation-count>15</api:citation-count><api:native><api:field name="altmetric-attention-score" type="integer" display-name="Altmetric attention score"><api:integer>3</api:integer></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="AU"><api:line type="organisation">The University of Sydney</api:line><api:line type="city">Sydney</api:line><api:line type="state">New South Wales</api:line><api:line type="country">Australia</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01056562742.28</api:identifier></api:identifiers></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="AU"><api:line type="organisation">The University of Sydney</api:line><api:line type="city">Sydney</api:line><api:line type="state">New South Wales</api:line><api:line type="country">Australia</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01165325611.83</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10975217</api:identifier></api:identifiers></api:field><api:field name="field-citation-ratio" type="decimal" display-name="Field citation ratio"><api:decimal>2.47</api:decimal></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Diabetic Medicine</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc">Prevention</api:keyword><api:keyword scheme="rcdc">Cardiovascular</api:keyword><api:keyword scheme="rcdc">Health Services</api:keyword><api:keyword scheme="rcdc">Aging</api:keyword><api:keyword scheme="rcdc">Cost Effectiveness Research</api:keyword><api:keyword scheme="rcdc">Diabetes</api:keyword><api:keyword scheme="rcdc">Clinical Research</api:keyword><api:keyword scheme="rcdc">Nutrition</api:keyword><api:keyword scheme="hrcs-rac">4.4 Population screening</api:keyword><api:keyword scheme="hrcs-rac">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac">4.2 Evaluation of markers and technologies</api:keyword><api:keyword scheme="hrcs-hc">Metabolic and endocrine</api:keyword><api:keyword scheme="hrcs-hc">Cardiovascular</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Blood Glucose</api:keyword><api:keyword scheme="mesh">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh">Decision Trees</api:keyword><api:keyword scheme="mesh">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh">Fasting</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Life Expectancy</api:keyword><api:keyword scheme="mesh">Mass Screening</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>13</api:day><api:month>1</api:month><api:year>2002</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Closed Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Wiley</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.3</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="242009" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000088304000009" last-modified-when="2024-03-14T05:59:13.193+00:00"><api:citation-count>18</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000088304000009&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1046/j.1464-5491.2000.00308.x</api:text><api:links><api:link type="doi" href="http://doi.org/10.1046/j.1464-5491.2000.00308.x"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1046/j.1464-5491.2000.00308.x"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1464-5491</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">336LR</api:identifier><api:identifier scheme="pubmed">10975217</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>DIABETIC MEDICINE</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>decision analysis</api:keyword><api:keyword>QALYs</api:keyword><api:keyword>screening</api:keyword><api:keyword>Type 2 diabetes mellitus</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>2000</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record><api:record format="native" id="25166" source-id="3" source-name="wos" source-display-name="Web of Science" id-at-source="WOS:000088304000009" last-modified-when="2014-07-25T11:08:28.747+01:00"><api:citation-count>12</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:links><api:link type="elements/user" id="1003" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/1003"/></api:links><api:last-name>Goyder</api:last-name><api:initials>EC</api:initials><api:first-names>EC</api:first-names><api:separate-first-names><api:first-name>E</api:first-name><api:first-name>C</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Irwig</api:last-name><api:initials>LM</api:initials><api:first-names>LM</api:first-names><api:separate-first-names><api:first-name>L</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0742-3071</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>6</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>DIABETIC MED</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>decision analysis</api:keyword><api:keyword>QALYs</api:keyword><api:keyword>screening</api:keyword><api:keyword>Type 2 diabetes mellitus</api:keyword><api:keyword>FASTING PLASMA-GLUCOSE</api:keyword><api:keyword>CARDIOVASCULAR-DISEASE</api:keyword><api:keyword>COMPLICATIONS</api:keyword><api:keyword>NIDDM</api:keyword><api:keyword>RISK</api:keyword><api:keyword>HYPERTENSION</api:keyword><api:keyword>INTOLERANCE</api:keyword><api:keyword>PREVENTION</api:keyword><api:keyword>WHITEHALL</api:keyword><api:keyword>ADULTS</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>469</api:begin-page><api:end-page>477</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>6</api:month><api:year>2000</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Screening for Type 2 diabetes mellitus: a decision analytic approach</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>17</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword scheme="mesh" origin="record-data" source="pubmed">Blood Glucose</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Decision Trees</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Fasting</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Mass Screening</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Blood Glucose</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Mass Screening</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Fasting</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Decision Trees</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3202 Clinical Sciences</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Prevention</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Health Services</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Aging</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Cost Effectiveness Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Diabetes</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Clinical Research</api:keyword><api:keyword scheme="rcdc" origin="record-data" source="dimensions">Nutrition</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4.4 Population screening</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4 Detection, screening and diagnosis</api:keyword><api:keyword scheme="hrcs-rac" origin="record-data" source="dimensions">4.2 Evaluation of markers and technologies</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Metabolic and endocrine</api:keyword><api:keyword scheme="hrcs-hc" origin="record-data" source="dimensions">Cardiovascular</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Blood Glucose</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Cardiovascular Diseases</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Decision Trees</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diabetes Mellitus, Type 2</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Diabetic Angiopathies</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Fasting</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Life Expectancy</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Mass Screening</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword origin="record-data" source="wos-lite">decision analysis</api:keyword><api:keyword origin="record-data" source="wos-lite">QALYs</api:keyword><api:keyword origin="record-data" source="wos-lite">screening</api:keyword><api:keyword origin="record-data" source="wos-lite">Type 2 diabetes mellitus</api:keyword><api:keyword origin="record-data" source="wos">decision analysis</api:keyword><api:keyword origin="record-data" source="wos">QALYs</api:keyword><api:keyword origin="record-data" source="wos">screening</api:keyword><api:keyword origin="record-data" source="wos">Type 2 diabetes mellitus</api:keyword><api:keyword origin="record-data" source="wos">FASTING PLASMA-GLUCOSE</api:keyword><api:keyword origin="record-data" source="wos">CARDIOVASCULAR-DISEASE</api:keyword><api:keyword origin="record-data" source="wos">COMPLICATIONS</api:keyword><api:keyword origin="record-data" source="wos">NIDDM</api:keyword><api:keyword origin="record-data" source="wos">RISK</api:keyword><api:keyword origin="record-data" source="wos">HYPERTENSION</api:keyword><api:keyword origin="record-data" source="wos">INTOLERANCE</api:keyword><api:keyword origin="record-data" source="wos">PREVENTION</api:keyword><api:keyword origin="record-data" source="wos">WHITEHALL</api:keyword><api:keyword origin="record-data" source="wos">ADULTS</api:keyword><api:keyword scheme="for" origin="issn-inferred">1103 Clinical Sciences</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="for" origin="issn-inferred">1701 Psychology</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Endocrinology &amp; Metabolism</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3202 Clinical sciences</api:keyword></api:keywords></api:all-labels><api:journal issn="0742-3071" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973815" title="Diabetic Medicine"><api:records><api:record source-name="summary"><api:title>Diabetic Medicine</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/1258/relationships"/></api:object></api:result></api:response>